James is the Wellcome Trust Observer on the Stevenage Bioscience Catalyst Board.

At Wellcome, James is Head of the Innovations Transition team with responsibility for a broad portfolio of translational projects across the pharmaceutical and life sciences sector. Prior to this he was Head of Planning Analysis and Delivery for the Innovations team, leading a team whose remit it was to monitor and report on project and portfolio progress.  James is a qualified accountant and has a broad range of finance experience covering commercial finance, group reporting, corporate finance and assurance.